I'm co-founder and CSO of LifeNome, after 20+ years in computational cancer genomics.
I joined forces with Ali Mostashari in 2016 to personalize nutrition, fitness, and skincare from DNA.
I've questioned an ovarian-age result at 35 from a model trained only on women aged 42 to 55.
I bought "revolutionary" NAD⁺ skincare myself. When I went looking for the data behind it, I didn't find much.
Preparing it, I saw how fast the field had grown. Now I argue skin data must be integrated, not siloed.
I earned my PhD at Israel's Weizmann Institute and was a Royal Society Dorothy Hodgkin Fellow at Cambridge.
I'm co-founder and CSO of LifeNome, after 20+ years in computational cancer genomics.
I joined forces with Ali Mostashari in 2016 to personalize nutrition, fitness, and skincare from DNA.
I've questioned an ovarian-age result at 35 from a model trained only on women aged 42 to 55.
I bought "revolutionary" NAD⁺ skincare myself. When I went looking for the data behind it, I didn't find much.
Preparing it, I saw how fast the field had grown. Now I argue skin data must be integrated, not siloed.
I earned my PhD at Israel's Weizmann Institute and was a Royal Society Dorothy Hodgkin Fellow at Cambridge.
By using this service, you agree to the Terms of Service and Privacy Policy.